Understanding why some latina women discontinue participation in cancer prevention outreach

July 25, 2015, Roswell Park Cancer Institute

It has long been known that rates of breast and cervical cancer screening among Latinas are low compared to rates for U.S. women overall. A study led by researchers at Roswell Park Cancer Institute (RPCI) found that age and fear of cancer diagnosis are among the reasons why Latina women do not continue participation following breast and cervical cancer education programs. The research was published in the Journal of Health Communication: International Perspectives.

This research is a secondary analysis of a large randomized, controlled study reported earlier and was designed to specifically understand the characteristics of women who were lost to attrition for follow-up telephone calls following participation in the multisite, peer-led education program Esperanza y Vida (EyV).

Esperanza y Vida aims to address the low rates of breast and screening in the diverse Latina population and offers information and education in community settings delivered by lay health advisers and sobreviventes (). A narrative from the sobreviventes incorporates personal experiences to promote learning and increase self-efficacy for pap and mammography screenings.

In that earlier EyV intervention study, a participant was considered lost to follow-up if, for example, she did not provide a telephone number at registration, declined to complete the follow-up questions, or did not have a working telephone number. The secondary analysis only examined attrition at two months, as women lost to follow-up at this time were dropped from further analysis. Of the 908 Latina women who participated in the cancer education program and consented to follow-up, 76% were retained at the two-month follow-up assessment.

"Participant loss to follow-up represents a potentially important source of bias in research studies," says Deborah Erwin, PhD, Principal Investigator of the study and Director of the Office of Cancer Health Disparities Research at Roswell Park. "These findings are underscored by the fact that while there was a very high response rate for follow-up assessment two months after the program (77%)—especially for a group that includes many non-English-speaking, foreign-born women—unscreened women at that time could receive navigation assistance for screening, and the women lost to follow-up (23%) may remain unscreened without additional assistance."

Analysis of the data found that Latinas lost to attrition at the two-month follow-up assessment included women who were younger than 40 years of age (59.6%; most women in this group were ineligible for mammograms, but eligible for pap tests); those who felt that hearing a survivor's story would lead them to make an appointment for preventive screening (17.6%); and women who were afraid of hearing medical results (43.2%). More research would be required to determine whether the group of women impacted by a survivor's personal experiences went on to obtain screening on their own. The large share of women who were concerned about hearing medical results and who were no longer participating in the study demonstrates the continued need to address fears and emotional issues around screening.

"Knowing more about the reasons behind attrition characteristics provides insight for future studies," adds Dr. Erwin. "These findings contribute to the literature regarding the recruitment and retention of minorities, specifically Latinas and newer immigrants, in research studies, as well as to how attrition and the ability to follow up with Latina women of varying ages are understood."

Explore further: Can patient navigators reduce no-shows for cancer screening follow-up?

More information: Journal of Health Communication, Volume 20, Issue 7, 2015. DOI: 10.1080/10810730.2015.1018596

Related Stories

Can patient navigators reduce no-shows for cancer screening follow-up?

July 23, 2015
Researchers at Harvard Medical School and Brigham and Women's Hospital reported a 20% decline in the rate of missed appointments for cervical cancer evaluation following a Pap smear when a patient navigator program was initiated ...

What's the best test for cervical cancer? Pap, HPV or both?

June 9, 2014
Should U.S. women be screened for cervical cancer with Pap tests, HPV tests or both? According to researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) while the merits of screening ...

False breast cancer alarm has negative impact on health

May 27, 2015
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been ...

Study finds decreased rates of high-grade cervical lesions in young women

June 22, 2015
A new analysis indicates that rates of high-grade cervical lesions decreased in young U.S. women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes ...

Millions given access to breast, cervical cancer screening: CDC

August 7, 2014
(HealthDay)—Millions of American women have benefited from a breast and cervical cancer screening program offered by the U.S. Centers for Disease Control and Prevention, according to a new report.

Interactive phone messages may promote cancer screening

March 27, 2014
(HealthDay)—Underserved Latina patients view interactive voice response (IVR) messages as an acceptable strategy to promote cancer screening, according to a study published online March 13 in the U.S. Centers for Disease ...

Recommended for you

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.